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Abstract
Despite proven efficacy of cardiac rehabilitation (CR) in reducing the all-cause mortality in patients 
after myocardial revascularization, the penetration of CR, due to patient-related factors and referral 
rates remains limited. To improve the outcomes, home-based tele-rehabilitation (TR) has been proposed 
recently. In theory TR enhances the effects of standard CR procedures due to implementation of an 
intelligent monitoring system designed to ensure optimal training through on-demand transmission of 
vital signs, aimed at motivating the patients through daily schedule reminders, setting daily goals and 
creating a platform for mutual feedback. Several meta-analyses assessing various studies comparing 
these two methods (CR and TR) have proven that they are at least equally effective, with some of the 
research showing superiority of TR. Although there was a small sample size, lack of long-term follow-up, 
reporting effects of TR itself, no integration with tools designed for coaching, motivating and promot-
ing a healthy lifestyle constitutes an important limitation. The latter carries a hopeful prognosis for 
improvement when utilizing a broad-spectrum approach, especially with use of dedicated technological 
solutions exploiting the fact of a large and yet rapidly increasing penetration of smartphones, mobile 
PCs and tablets in the population. The above-mentioned findings worked as the basis and rationale for 
commencing the RESTORE project aimed at developing and delivering state-of-the-art, comprehensive 
TR for patients after myocardial revascularization and evaluating its molecular aspect in view of how 
it influences the atherosclerosis progression attenuation. This paper presents the current state and ra-
tionale behind the project based on up-to-date TR efficacy data. (Cardiol J 2019; 26, 5: 594–603)
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Introduction
The worldwide prevalence of cardiovascular 
diseases (CVD) has been increasing during the last 
few decades, and is the main cause of mortality in 
Europe with 3.9 million deaths each year accord-
ing to European Cardiovascular Disease Statistics 
2017, it also generates  a staggering cost of €210 
billion a year [1]. Coronary artery disease (CAD) 
accounts for 45% of all deaths from CVD and is 
the single most prominent cause of mortality [1]. 
With recent advances in diagnostics and therapy of 
CAD, including percutaneous coronary interven-
tions (PCI) with new generation stent implantation, 
modern pharmacotherapy and minimally invasive 
surgical procedures, patient survival has improved, 
although long-term prognosis remains unsatis-
factory. For instance, 1-year mortality following 
myocardial infarction (both ST-segment elevation 
myocardial infarction [STEMI] and non-ST-seg-
ment elevation myocardial infarction [NSTEMI]) 
in Poland, based on nationwide AMI-PL database 
was as high as 19.4% [2]. The increased risk of 
cardiac events is further associated with a high 
frequency of hospital re-admissions, resulting in a 
serious quality of life issue and negative economic 
impact. To reduce the risk and improve prognosis, 
the treatment strategy should not be limited to 
on-site intervention but encompass a full range of 
actions directed to ensure a complete recovery and 
long-term maintenance. Current European Society 
of Cardiology (ESC) guidelines recommend prompt 
implementation of extensive cardiac rehabilita-
tion (CR) for all patients with ST-elevation acute 
myocardial infarction (Class I, Level B), NSTEMI 
(Class IIa, Level A) and stable coronary artery 
disease (Class I, Level A) [3]. The benefits of CR 
as a method of secondary prevention for patients 
with CAD are widely known and well documented. 
Numerous studies have demonstrated that CR is 
associated with significant reduction in all-cause 
mortality in patients after myocardial revasculari-
zation [4–7]. Ten-year follow-up analysis in patients 
who underwent percutaneous intervention due to 
acute coronary syndrome showed an almost 40% 
decrease in mortality in a group of CR patients in 
comparison to non-CR patients (14.7% vs. 23.5%) 
[8]. Further potential advantages include reduc-
tion in symptoms, improvement in exercise toler-
ance and physical work capacity, improvement in 
psychosocial well-being, quality of life and stress 
management, attenuation of the atherosclerotic 
processes, decreased risk of subsequent coro-
nary events and revascularization, and a reduced 
frequency of hospital readmission. Despite undis-
puted benefits, due to patient-related factors and 
referral rates, CR penetration remains limited [9]. 
In European countries less than one-half of 
the coronary patients access cardiac prevention 
and rehabilitation programs [10]. Similar num-
bers occur in the population of the United States 
[11–13]. The most significant patient-related 
barriers encompass lack of resources, attitude 
problems, differences in geographic distribution 
of stationary rehabilitation centers among regions 
resulting in long distances, restrictions in access 
to appropriate services as well as reimbursement 
issues. Additionally, CR participation is further 
impaired by a failure to motivate patients to life-
style changes, coupled with an inability to track 
progress and efficacy of rehabilitation programs. 
The major disadvantage of current CR programs 
is their relatively short duration without long-term 
follow-up, which discourages the development 
of sustainable changes in a patients’ lifestyle. To 
improve outcomes, home-based tele-rehabilitation 
(TR) has been proposed recently. In theory TR 
enhances the effects of standard CR procedures 
due to the implementation of an intelligent moni-
toring system designed to ensure optimal training 
through on-demand transmission of vital signs such 
as electrocardiogram (ECG) and both the physical 
and mental state of patients. Moreover, it aims to 
motivate patients, reminding them of scheduled 
activities, setting daily goals, creating a platform 
for mutual feedback and thus promote shaping 
of new habits. Several meta-analyses assessing 
various studies comparing these two methods 
(CR and TR) have proven that they are at least 
equally effective, with some of the research show-
ing a superiority of TR in terms of the frequency 
of adverse events, rehospitalization rate, physical 
activity levels, adherence to physical activity guide-
lines and both low-density lipoprotein and diastolic 
blood pressure levels (Table 1) [14–17]. However, 
significant limitations of a greater proportion of 
the studies were the relatively small sample size, 
lack of long-term follow-up and reporting effects 
of TR itself, lack of integration with tools designed 
for coaching, motivating the patient and promot-
ing a healthy lifestyle. The latter carries a hopeful 
prognosis for improvement when utilizing a broad-
spectrum approach, especially the use of dedicated 
technological solutions which exploit a large and 
yet rapidly increasing penetration of smartphones, 
mobile PCs and tablets in the population. Addition-
ally, the lack of guidelines in this matter further 
highlights the need for large randomized studies 
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to be conducted. The above-mentioned findings 
worked as a basis and rationale for commencing 
the RESTORE project aimed at developing and 
delivering state-of-the-art, comprehensive TR 
for patients after myocardial revascularization. 
The project is substantially funded by the Polish 
National Centre for Research and Development. 
The project obtained local bioethics committee 
approval (Bioethics Committee in Bielsko-Biala; 
approval no. 2016/02/11/05). 
Clinical Trial Information
Utilization of Telemedicine in Optimal Cardiac 
Rehabilitation Program in Patients After Myocardi-
al Revascularization (RESTORE); NCT03375944; 
https://clinicaltrials.gov/ct2/show/NCT03375944. 
Restore project
Objectives
The aim of the RESTORE project was to de-
termine an optimal cardiac rehabilitation (OCR) 
strategy using novel medical technologies and 
ensuring comprehensive CR through effective 
patient monitoring utilizing a remotely controlled 
CR program to decrease annual mortality and risk 
of cardiovascular events in CAD patients at 9 and 
12-month follow-up (with an expected decrease to 
fall below 0.5%). Additionally, an intensive dietary 
and educational program focused on lifestyle and 
risk factor modification to be implemented. As 
a novelty, the intravascular imaging with athero-
sclerotic plaque and intraarterial lipid characteri-
zation combined with a molecular aspect of OCR 
will also be evaluated in view of how it influences 
atherosclerosis progression attenuation. Primary 
endpoint will be maximum lipid core burden index 
(LCBI; 4 mm) and secondary endpoints (among 
others): change in the amount of LCBI and change 
in the angle of lipid core.
Combining all these components should help 
to establish  new strategies translating into up-to-
date CR and secondary prevention of cardiovas-
cular events. To properly initiate and conduct this 
study the RESTORE Consortium has been created, 
consisting of prime Polish and European science 
and industry representatives led by American 
Heart of Poland SA.
Methodology 
The project was split into key phases. The step-
wise approach will ensure that any problems encoun-
tered during the study will be identified and resolved 
quickly, allowing timely execution of the project.
The first and crucial part of the project will 
be to design and build the platform of optimal 
home-based cardiac TR. The platform will consist 
of four critical and synchronized elements that 
enable fluent, efficient and safe operation of the 
Table 1. Comparison between tele-rehabilitation and center-based rehabilitation programs (based on 
review analyses).
Author Year Type  
of study
No. of trials/ 
/patients
Primary  
endpoint
Additional  
observations
Frederix et al. 
[14]
2015 Systematic  
review
37 trials Impact on adverse 
events and RR: 
Favors TR  
(1.30 [1.13–1.50])
Adherence to  
physical activity: 
Favors TR  
(0.56 [0.45–0.69])
Huang et al. 
[16]
2015 Systematic  
review
9 trials/1546  
patients
No statistical  
difference in  
all-cause mortality
Comparable in exercise  
capacity, lipid profile,  
QoL, BP
Hwang et al. 
[17]
2015 Systematic  
review
11 trials No difference in 
exercise capacity 
expressed as 6MWD 
and VO2 peak 
Higher adherence rates  
of TR compared to CBR,  
no difference in QoL
Rawstorn et al. 
[15]
2016 Systematic  
review
11 trials/1189  
patients
Physical activity 
level and exercise 
adherence:
Both favors TR 
(0.42 [0.21–0.64]; 
§0.75(28))
TR and CBR were comparably  
effective for improving  
maximal aerobic  
exercise capacity  
and other modifiable  
CV risk factors
Statistical results presented as: odds ratio [95% confidence interval]. 6MWD — 6-minute walk distance; BP — blood pressure; CBR — center-
based rehabilitation; CV — cardiovascular; QoL — quality of life; RR — rehospitalization rate; TR — tele-rehabilitation
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whole system. The elements include: (1) dedicated 
software for remote patient monitoring, which 
will be based on algorithms that allow automatic 
analysis of physiological signals; (2) peripheral 
medical devices that measure physiological signals 
including ECG, heart rate, and blood pressure; 
(3) a central system (coordinating center) that col-
lects physiological parameters and to help medical 
staff and implemented algorithms allowing for 
rapid action in order to improve patient safety; 
(4) mobile applications which help patients manage 
their health status and allow for data transmission 
between medical devices and central system. Once 
all these devices are established and technologi-
cal requirements met, the technical tests will be 
conducted. After positive testing, progression to 
the next phase and use of the system in a clinical 
setting will be enabled.
The next step is comprised of a prospective 
and randomized multi-center study including 
5 cardiology units located in the Polish cities of 
Tychy, Bielsko-Biala, Dabrowa, Ustron, Chrzanow 
(Fig. 1). All patients enrolled in the study must be 
younger than 70 years old, presenting with stable 
or non-ST-elevation acute coronary syndrome 
(including NSTEMI and unstable angina) and 
must have completed coronary revascularization 
with any available method including coronary 
angioplasty, coronary artery bypass grafting or 
hybrid procedures. All lesions of ≥ 70% of diameter 
stenosis will be considered significant. If a lesion 
is assessed as 50–70% of diameter stenosis, addi-
tional imaging (intravascular ultrasound or optical 
coherence tomography) or functional (fractional 
flow reserve) tests will be performed at the physi-
cian’s discretion in order to confirm the significance 
Stable angina, unstable angina, NSTEMI
Coronary angiography
Coronary lesions > 70%
S
C
R
E
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N
I
N
G
T
R
I
A
L
C
L
I
N
I
C
A
L
Borderline lesions 50–70%
2
MLA by IVUS £ 4.0 mm
or FFR £ 0.80
Completed revascularization utilizing all
currently approved treatment strategies
Patient qualied to the study
2–3 weeks of stationary or ambulatory rehabilitation
including health and exercise education, smoking cessation, 
other risk factors modication + stress test
Randomization
Control group
with standard
medical care
Study group  with optimal cardiac
rehabilitation, including: comprehensive,
continuous and regularly controlled
telerehabilitation (exercise training, intensive
dietary and educational program focused on
lifestyle and risk factors modication)
Subgroup of 100 patients dsignated tp control angiography with
intravascular imaging at 9 months follow-up, to evaluate effects of
optimal cardiac rehabilitation on atherosclerosis regression
IVUS or FFR
2
MLA by IVUS ≥ 4.0 mm
or FFR ≥ 0.80
Patient disqualied from
the study
Figure 1. RESTORE randomized trial schematics; STEMI — ST-segment elevation myocardial infarction; IVUS — in-
travascular ultrasound; FFR — fractional flow reserve; MLA — minimal lumen area.
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of stenosis. In patients following myocardial infarc-
tion with extensive scar tissue, the imaging tests 
were performed in order to assess viability before 
assigning any patient for the study. In addition, all 
patients must have ejection fraction equal or above 
40%. The main inclusion and exclusion criteria are 
presented in Table 2. After revascularization was 
completed all patients will undergo 2 to 3 weeks of 
stationary (in-hospital) or outpatient (ambulatory) 
CR. This allows enough time for health and exer-
cise education, smoking cessation and other risk 
factor modifications. At the end of this period all pa-
tients will undergo a stress test, which will be then 
repeated at 9-month follow-up. During stationary or 
ambulatory rehabilitation all patients will be rand-
omized to one of the following groups: (A) control 
group with standard medical care — optimal medical 
therapy, regular check-ups (n = 500) or (B) study 
group with optimal, remotely controlled and intense 
CR (n = 500). Before randomization, all patients 
(n = 1000) will undergo technical training in order 
to get familiar with the TR program and medical de-
vices provided. Patient number justification is based 
on the following assumption: at least 630 patients 
are required to have a 90% chance of detection, 
and be significant at the 5% level, a decrease in the 
primary outcome measure from 4.5% in the control 
group [18] to 0.5% in the experimental group. Taking 
into account previous reports on adherence rates to 
regular physical exercise it was decided to increase 
the number of patients to 500 per group.
Additionally, a subgroup of 100 patients 
(50 in the study group and 50 in the control arm) 
in whom, based on angiography, vessels with 
borderline lesion was left untreated, will undergo 
combined intravascular imaging with intravascular 
ultrasound (IVUS) and near-infrared spectroscopy 
(NIRS) using the commercially available TVC Im-
aging System™ (Infraredx, Inc., Burlington, MA, 
USA) immediately following the last procedure 
and at 9-month follow-up (Fig. 2). The imaging will 
track potential changes in atherosclerotic plaque 
volume and composition (including the amount of 
intraarterial lipids) after optimal CR. The quanti-
tative and qualitative analysis will be performed 
in independent core laboratory. Furthermore, 
a group of 100 patients will be qualified to take 
part in an additional molecular sub-study in which 
selected particles and processes, that potentially 
could change following physical activity and the 
rehabilitation program will be evaluated. This in-
cludes, among other factors, the activity and level 
of antioxidative enzymes, signs of oxidative dam-
age to proteins, the expression of gene encoding 
enzymes involved in the defense against oxidative 
stress and markers of blood-brain-barrier integrity. 
Polymorphism of genes related to endothelial and 
vascular function will be studied in order to find 
possible predictors indicating a positive effect of 
rehabilitation in cardiovascular system disorders. 
Molecular studies will be conducted immediately 
after the last procedure and at 9-month follow-up 
in the Laboratory of Molecular Studies at the Acad-
emy of Physical Education in Katowice. 
Cardiac rehabilitation program
The essential part of the OCR program will 
be CR based on a protocol developed by an expe-
rienced cardiovascular team consisting of physi-
cians and physiotherapists from American Heart of 
Table 2. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Age over 18 and under 70
Completed revascularization  
in patients with stable, unstable  
angina or after NSTEMI
Eligibility to participate in a program 
of early cardiac rehabilitation
The ability to use tele-rehabilitation 
system
Signed informed consent form
Ejection fraction < 40%
Acute myocardial infarction with ST segment elevation/new onset of LBBB
Suboptimal (not completed) myocardial revascularization
Acute heart failure (Killip IV) at the time of admission to the hospital
Dual antiplatelet therapy cannot be maintained for 1 year after PCI
Hemorrhagic stroke in the past
Ischemic stroke or transient ischemia in previous 6 weeks
Platelet count < 100,000/mm3
Chronic renal failure with creatinine clearance < 30 mL/min/1.73 m2
Planned surgery
Pregnancy or planned pregnancies
Expected life expectancy less than 3 years after enrollment
LBBB — left bundle branch block; NSTEMI — non-ST-segment elevation myocardial infarction; PCI — percutaneous coronary intervention
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Poland SA and the Academy of Physical Education 
in Katowice. The optimal protocol development 
will be multi-level. The main steps are presented 
below: 
 — First level — qualification for the program 
of CR: at the beginning of stationary or ambu-
latory rehabilitation the following data will be 
analyzed: medical history, resting ECG, base-
line blood pressure and heart rate measure-
ments, complete blood count including lipid 
profile, glucose and electrolyte levels, body 
weight and body composition measurements. 
In all patients, cardiac echo will be performed. 
In addition, all patients will fill out question-
naires to assess their quality of life, physical 
activity and depression level. The crucial part 
of this step will be to perform a stress test us-
ing a treadmill or bicycle in order to qualify the 
patient for an adequate rehabilitation model. 
Before stress test initiation, target heart rate 
will be calculated using the following formula: 
85% of maximal heart rate (208-07 × age). In 
case of beta-blocker intake, heart rate will be 
adjusted (minus 20–30% heart rate sub-max). 
For the treadmill exercise, standard or modi-
fied Bruce protocols will be used. During the 
exercise ECG, blood pressure, heart rate and 
Borg scale will be used and monitored. 
 — Second level of rehabilitation (stationary 
or outpatient CR; duration 2–3 weeks): 
model A of CR will be designated for patients 
with the highest exercise tolerance, without 
angina or any other cardiovascular symp-
toms, and who have achieved the level of ≥ 7 
MET or ≥ 100 W in the stress test. Intensity: 
60–85% of heart rate reserve or 50–75 (80) % 
of maximal load. The exercise loads increase 
gradually through the whole period of reha-
bilitation. Model B and C of rehabilitation will 
be designated for patients with low exercise 
tolerance who achieved at least 6 MET or 
75 W during the initial stress test. Similar to 
model A, the exercise loads increase gradually. 
For all patients and  all models there will be 
a possibility for crossover (concerning patients 
unable to use the TR system). The follow-
ing types of training have been scheduled: 
(1) endurance (aerobic), (2) general training to 
improve a patients’ condition, (3) resistance 
training (aerobic, mixed into the last phase 
of the period). At the end of this phase all 
patients qualified to participate in the study 
group (OCR program) will receive a set of 
devices for cardiac TR, including a tablet with 
installed tele-rehabilitation software (designed 
and produced by the RESTORE Consortium), 
tele ECG with electrodes (ProPlus SA, War-
saw), blood pressure monitor and training bike 
(Kettler Polska Sp. z o.o., Poland). Patients 
will undergo  detailed training in order to get 
familiar with this technology. 
 — Third level of rehabilitation: (frequency: 
a minimum of 3 times per week, optimum 
5 times per week). Qualification of patients and 
exercise plan of rehabilitation will be similar 
to that described in the second level. Exercise 
Monitoring center evaluates
parmeters and if acceptable
send the patient approval
for exercise initation
Before the exercise
BP Monitor BP Monitor BP MonitorECG Device ECG Device ECG Device
Questionnaires Questionnaires
Baseline BP, ECG measurements
and lled questionnaire sent to MC
Patients starts the
exercise
Patients continues the
exercise
At the peak of the exercise the
system automatically performs
BP and ECG measurements and
send them to MC After the exercise patients sends the
BP, ECG measurements and lled
questionnaire again to MC
Peak of the exercise After the exercise
MONITORING 
CENTER
At anytime, in case of adverse events or incorrect BP,
ECG or questionnaire results MC can immediately
connect the patient and vice versa in order to consult
the problem and terminate the exercise if required
Figure 2. Concept and design of home training utilizing telemonitoring technology; BP — blood pressure; 
ECG — electrocardiogram; MC — Monitoring Center
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loads will be modified based on the Borg scale, 
heart rate (continuous monitoring during 
physical activity) and stress test performed 
every 3 months. There will be a possibility to 
cross over to the other model of rehabilitation. 
It will also be possible to include additional 
activities in order to improve patient motiva-
tion. These include: jogging, choreotherapy, 
spinning and other exercises. Furthermore, 
all patients will be encouraged to participate 
in periodic street races (including Nordic-
walking) over a distance of 5 km. During this 
phase all patients enrolled in the study group 
will be obliged to use this novel system of 
TR according to the instructions and training 
obtained during the second phase of station-
ary rehabilitation. The concept and design of 
home training which utilizes telemonitoring 
technology is presented in Figure 2. The sys-
tem allows medical staff to oversee patient 
parameters including ECG, blood pressure, 
extent of perceived exertion and quality of life. 
In addition, it allows monitoring of progress 
of exercise over time, remotely adjusting the 
exercise load (if required) and transferring 
information to the patient by displaying their 
progress in comparison to others.
Regardless of the intensity of their plan of ex-
ercise presented above, all patients will be educat-
ed during controlled ambulatory visits with regard 
to maintaining a proper diet, smoking cessation, 
risk factor modification and methods of excessive 
stress reduction. For all patients, echocardiography, 
stress test and blood analysis will be performed at 
1 and 9 months. These tests will be accompanied 
by a physical examination and mental evaluation 
using questionnaires identical to the second phase. 
Current state of the project  
(as of August 2018)
The project commenced in March 2016 and its 
completion is planned for December 2019. To date, 
the first phase of the project has been completed. 
The comprehensive TR platform has been estab-
lished and successfully tested confirming its effi-
cacy of use, thus enabling progression to the next 
phase. Recently the enrollment process has begun 
and 144 patients have been recruited to the study 
and intravascular imaging with blood sampling for 
molecular sub-study, which has been performed 
with the first 10 patients (Fig. 3). Also, first patients 
enrolled in the study group have already started 
their TR program that is being monitored by Center 
for Heart Monitoring built within the structure of 
the American Heart of Poland. Initial short-term 
results of the RESTORE project are expected at 
the end of 2018.
Discussion 
The abovementioned CVD statistics highlight 
the need for comprehensive solutions in order to 
reduce the burden of CVD diseases both for affect-
ed individuals and the whole medical care system. 
The state-of-the-art therapy cannot be limited to 
on-site treatment but rather needs to be combined 
with a well-thought-out strategy aimed at bring-
ing patients to full recovery, mobilizing them and, 
through a deep modification of their daily habits, 
establishing a highly effective preventive strat-
egy for the future. The current guidelines of ESC 
recommend implementing CR from the very first 
moment after intervention to ensure accelerated 
patient convalescence [3]. The value and impact of 
CR have been thoroughly checked and confirmed in 
numerous studies, showing a significant decrease 
in 1-year mortality [4–6]. Sunamura et al. [8] re-
ported an almost 40% reduction in overall mortality 
at 10-year follow-up in a group of CR patients in 
comparison to non-CR patients.
In most countries CR is delivered as a su-
pervised center-based program. The necessity to 
attend scheduled trainings can be restricted by geo-
graphical and associated economic barriers, drasti-
cally reducing the number of attendees. Therefore, 
despite such encouraging results regarding CR 
efficacy, the general aptitude and patient compli-
ance remains unsatisfactory. Studies show that 
merely 20% to 50% (up to 65% in several coun-
tries) of eligible individuals participate in CR in 
developed countries [19–23]. The causes differ, but 
decisive actions aiming to resolve this matter are 
undoubtedly required. Implementing home-based 
rehabilitation (HBR) could be seen as a partial so-
lution due to improved accessibility. Metanalysis 
conducted by Buckingham et al. [24] on 17 studies 
with 2172 patients included, proved non-inferiority 
of HBR in comparison to center-based CR. What 
is more,  the aspect of patient compliance as well 
as the probability of completing the whole course, 
HBR appears to be slightly superior. These find-
ings were later confirmed with two other reviews 
by Anderson et al. [25] and Zwisler et al. [26], 
concluding that both forms of rehabilitation are 
similarly effective for the condition of a patient’s 
health and improvement in quality of life,  hinting 
at a positive impact of increased compliance in the 
HBR group. However, significant limitations of the 
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abovementioned studies include a short follow-up 
time, with only 3 papers exceeding 1-year obser-
vation, as well as the relatively small number of 
patients included in individual trials, thus requiring 
further examination. 
Yet the question of how to make the impact of 
CR long-lasting still remains. Along with completing 
the CR program, usually spanning several weeks, 
the supervision is ceased, and the patient is left 
alone. According to a meta-analysis of 26 randomized 
clinical trials by ter Hoeve et al. [27], center-based 
CR is not sufficient to establish sustainable physical 
activity habits. Hence, better methods and solutions 
to provide feedback after completing the core CR 
are required.
The RESTORE project was created in 2014 to 
answer this challenge. The advantages of TR have 
been studied and its efficacy confirmed, but the low 
number of trials requires further examination [14–
–17]. The large number of patients to be included 
in the present study boosts the significance of this 
research. Additionally, the authors aim to conduct a 
long-term observation (obligatory 1-year follow-up 
with possibility to extend up to a 5 year follow-up) 
with periodical check-up not only to determine its 
impact on mortality and morbidity, but to determine 
whether via constant tele-monitoring, changes in 
one’s lifestyle, physical activity and dietary habits, 
the positive impact of CR can be maintained. What 
is more, the imaging sub-study will be performed 
in order to assess progression, regression or sta-
bilization of atherosclerotic plaques. In parallel 
a molecular sub-study will evaluate the levels of 
inflammatory and oxidative stress markers and 
endothelial function related genes with the aim of 
finding possible predictors of a positive effect of 
rehabilitation in cardiovascular system disorders. 
To enhance patient education and promote healthy 
living the RESTORE team has launched a program 
called “Active Heart” that will encourage cardio-
vascular patients to undertake regular, monitored 
physical activity. Their dedication will then be 
gratified by sponsors and all the funds raised in the 
program will be given to the charity. 
Figure 3. Greyscale intravascular ultrasound (IVUS) with near-infrared spectroscopy (NIRS) imaging of non-treated 
left main (LM) coronary artery with borderline atherosclerotic lesions performed in first patient enrolled to RESTORE 
imaging sub-study. A. Longitudinal view of LM with overlapping block chemogram presenting yellow segments with 
lipid-rich plaques (the asterisk shows mid part of LM) and red segments non-lipidic plaques (the hash shows distal 
part of LM); B. Angiographic view of LM; C. Cross sectional view of lipid-rich plaque in Segment 4 with maximum 
lipid core burden index (LCBI) equaled to 367; D. Cross sectional view of non-lipid plaque.
Left main mid part
Minimum Lumen Area = 10.02 mm2
Plaque Burden = 42.68%
LCB14 mm: 367
Left main distal
Minimum Lumen Area = 9.21 mm2
Plaque Burden = 49.90%
A B
C D
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Conclusions
This novel approach will enable outlining of 
possible flaws, gain a better understanding of the 
whole process and draw conclusions resulting in 
further improvement of optimal CR. Moreover, the 
underlying concept of the RESTORE project fulfils 
the expectations of the future role of CR being 
simultaneously easily accessible, comprehensive 
and cost-effective.  
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